Two Sides On NMN In US: NPA Asks Court To Allow Use, ChromaDex Applauds FDA's Exclusion

Trade group files complaint after member firm’s NMN import seized by FDA and agency doesn’t act on its petition asking for allowing the ingredient’s use in supplements. Nicotinamide riboside ingredient and supplement firm ChromaDex, however, applauds US prohibition of NMN.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation